| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0772 |
| Trial ID | ChiCTR1800019234 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | A clinical study evaluating CD19 CAR-T in the treatment of refractory and relapsed B-cell acute lymphoblastic leukemia/invasive B-cell non-Hodgkin's lymphoma |
| Year | 2018 |
| Country | China |
| Company sponsor | Shanghai Sixth People's Hospital |
| Cohort 1 | |||||
|
|||||